Advertisement
Screener

PHIO PHARMACEUTICALS CORP. (PHIO) Form DEFA14A: Additional definitive proxy soliciting materials

PHIO PHARMACEUTICALS CORP. Form DEFA14A: Additional definitive proxy soliciting materials

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-08-14: Form DEFA14A; Description ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS; Document phio_defa14a.htm.
  • 2025-08-28: Form DEFA14A; Description ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS; Document phio_defa14a.htm.
  • 2025-07-30: Form DEFA14A; Description ADDITIONAL DEFINITIVE PROXY MATERIALS; Document phio_defa14a.htm.
  • 2024-05-08: Form DEFA14A; Description FORM DEFA14A; Document phio_defa14a.htm.
FiledFormPeriod of reportDescriptionDocument
2026-08-14DEFA14AADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALSphio_defa14a.htm
2025-08-28DEFA14AADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALSphio_defa14a.htm
2025-07-30DEFA14AADDITIONAL DEFINITIVE PROXY MATERIALSphio_defa14a.htm
2024-05-08DEFA14AFORM DEFA14Aphio_defa14a.htm
2023-06-09DEFA14APROXY CARDphio_defa14a.htm
2022-12-02DEFA14AADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALSphio_defa14a.htm
2022-06-30DEFA14ADEFA14Aphio_defa14a.htm
2021-05-06DEFA14ADEFA14Aphio_defa14a.htm
2020-08-28DEFA14ADEFINITIVE ADDITIONAL MATERIALSphio_defa14a.htm
2019-12-13DEFA14AADDITIONAL PROXY MATERIALSphio_defa.htm
2019-12-13DEFA14ANOTICE AND PROXY STATEMENTphio_defa14a.htm
2019-10-25DEFA14ADEFINITIVE ADDITIONAL MATERIALSphio_defa14a.htm
2019-10-15DEFA14ADEFA14Aphio_defa14a.htm
2019-10-11DEFA14ADEFINITIVE OTHER INFORMATIONphio_defa.htm
2019-08-30DEFA14ADEFINITIVE INFORMATION STATEMENTphio_defa.htm
2018-04-26DEFA14ADEFA14Ad563605ddefa14a.htm
2017-04-27DEFA14ANOTICE AND ACCESSd366780ddefa14a.htm
2016-11-04DEFA14ADEFA14Ad268475ddefa14a.htm
2015-04-16DEFA14ADEFINITIVE ADDITIONAL MATERIALSd902092ddefa14a.htm
2014-04-15DEFA14ADEFA14Ad703460ddefa14a.htm
2013-04-26DEFA14ADEFA14Ad524399ddefa14a.htm

Similar stocks

Stock NameCountryMarket CapPE Ratio
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
BIOVIE INC. (BIVI)United States$0.012B
Dare Bioscience, Inc. (DARE)United States$0.011B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Moleculin Biotech, Inc. (MBRX)United States$0.011B
MetaVia Inc. (MTVA)United States$0.011B-0.65
KALA BIO, Inc. (KALA)United States$0.011B-3.33